title: Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas.
authors: B
authors: B
authors: Falini
authors: D
authors: D
authors: Lenze
authors: R
authors: R
authors: Hasserjian
authors: S
authors: S
authors: Coupland
authors: D
authors: D
authors: Jaehne
authors: C
authors: C
authors: Soupir
authors: A
authors: A
authors: Liso
authors: M P
authors: MP
authors: Martelli
authors: N
authors: N
authors: Bolli
authors: F
authors: F
authors: Bacci
authors: V
authors: V
authors: Pettirossi
authors: A
authors: A
authors: Santucci
authors: M F
authors: MF
authors: Martelli
authors: S
authors: S
authors: Pileri
authors: H
authors: H
authors: Stein
mesh_terms: D003593:Cytoplasm; D006801:Humans; D007951:Leukemia, Myeloid / Q000235:genetics / Q000473:pathology*; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics*; D000090243:Nucleophosmin; D012509:Sarcoma / Q000235:genetics / Q000473:pathology*
chemical_list: C000716967:NPM1 protein, human; D009687:Nuclear Proteins; D000090243:Nucleophosmin